The efficacy and safety of direct factor Xa inhibitors versus vitamin K antagonists for atrial fibrillation in patients on hemodialysis: a meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

The efficacy and safety of direct factor Xa inhibitors versus vitamin K antagonists for atrial fibrillation in patients on hemodialysis: a meta-analysis of randomized controlled trials

Published:2023-08-21 Issue:6 Volume:36 Page:736-743
ISSN:0899-8280
Container-title:Baylor University Medical Center Proceedings
language:en
Short-container-title:Baylor University Medical Center Proceedings

Author:

Abuelazm Mohamed¹,Mahmoud Abdelrahman²,Ali Shafaqat³,Gamal Mohamed¹^ORCID,Elmezayen Ahmed⁴,A. Elzeftawy Mohamad¹,Abdelazeem Basel⁵

Affiliation:

1. Faculty of Medicine, Tanta University, Tanta, Egypt

2. Faculty of Medicine, Minia University, Minia, Egypt

3. Department of Internal Medicine, Louisiana State University, Shreveport, Louisiana, USA

4. Department of Cardiothoracic Surgery, Manchester Foundation Trust, Manchester University, Manchester, UK

5. Department of Cardiology, West Virginia University, Morgantown, West Virginia, USA

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/08998280.2023.2247958

Reference30 articles.

1. Atrial fibrillation. The most common arrhythmia;Wyndham CRC.;Texas Heart Inst J,2000

2. Chronic Kidney Disease and the Risk of New-Onset Atrial Fibrillation: A Meta-Analysis of Prospective Cohort Studies

3. The prevalence of and factors associated with chronic atrial fibrillation in Medicare/Medicaid-eligible dialysis patients

4. Prevalence of Atrial Fibrillation and Associated Factors in a Population of Long-Term Hemodialysis Patients

5. Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factor Xa inhibitors in hemodialysis: OK—for now!;Baylor University Medical Center Proceedings;2023-09-08